US Stock MarketDetailed Quotes

CNTX Context Therapeutics

Watchlist
  • 1.4101
  • +0.0301+2.18%
Close Apr 26 16:00 ET
  • 1.3800
  • -0.0301-2.13%
Post 18:41 ET
22.51MMarket Cap-940P/E (TTM)

Context Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Context Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.42

-90.91%
Analyst Rating

Buy

Mar 22, 2024

Context Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
--2022/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
--2022/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Context Therapeutics Earnings Reports

  • Context Therapeutics | 10-K: Annual report

    Mar 21 19:40

  • Context Therapeutics: Q3 2023 Earnings Report

    Nov 10, 2023 05:04

  • Context Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 10, 2023 04:04

  • Context Therapeutics | 10-Q: Q1 2023 Earnings Report

    May 11, 2023 04:34

    • Read more

    Analysis

    Analyst Rating

    Updated: Mar 22, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg